Literature DB >> 22996831

Accuracy of low-dose rubidium-82 myocardial perfusion imaging for detection of coronary artery disease using 3D PET and normal database interpretation.

Tyler Kaster1, Ilias Mylonas, Jennifer M Renaud, George A Wells, Rob S B Beanlands, Robert A deKemp.   

Abstract

BACKGROUND: Our aim was to develop a normal database to be used for quantification of myocardial perfusion and diagnosis of "obstructive coronary artery disease" (CAD) using low-dose rubidium-82 three-dimensional (3D) positron emission tomography (PET)-CT.
METHODS: From a record of 1,501 patients, 77 were identified as having low-likelihood (LLK) of CAD. Forty LLK patients were used to construct a normal database using 4DM-PET, the remainder used for validation of normalcy. A group of 70 patients with CAD who had invasive coronary angiography and PET-CT were used to evaluate the accuracy of the database for detecting CAD using the sum-stress-score. The effect of clinical exclusion criteria and the inclusion of LLK patients were evaluated.
RESULTS: The normal database for CAD detection had a normalcy rate of 95%. Sensitivity was 100% for detecting patients with either 50% or 70% stenosis. Optimal specificity was 87% for either 50% or 70% stenosis. For localizing disease at 50% stenosis in the left anterior descending, left circumflex, and right coronary artery, sensitivity ranged from 59% to 68%, while specificity was maintained at 87-89%. Similarly, at 70% stenosis, sensitivity ranged from 64% to 79%, and specificity from 87% to 91%.
CONCLUSIONS: A normal database containing the relative perfusion scores of patients with LLK of CAD can be used to accurately diagnose obstructive coronary disease using low-dose Rb-82 with 3D PET-CT imaging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22996831     DOI: 10.1007/s12350-012-9621-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  30 in total

Review 1.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.

Authors:  Manuel D Cerqueira; Neil J Weissman; Vasken Dilsizian; Alice K Jacobs; Sanjiv Kaul; Warren K Laskey; Dudley J Pennell; John A Rumberger; Thomas Ryan; Mario S Verani
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Quantitative analysis of tomographic stress thallium-201 myocardial scintigrams: a multicenter trial.

Authors:  K F Van Train; J Maddahi; D S Berman; H Kiat; J Areeda; F Prigent; J Friedman
Journal:  J Nucl Med       Date:  1990-07       Impact factor: 10.057

3.  Quantitative same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality.

Authors:  K F Van Train; J Areeda; E V Garcia; C D Cooke; J Maddahi; H Kiat; G Germano; G Silagan; R Folks; D S Berman
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

4.  Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT.

Authors:  Fabio P Esteves; Jonathan A Nye; Akbar Khan; Russell D Folks; Raghuveer K Halkar; Ernest V Garcia; David M Schuster; Stamatios Lerakis; Paolo Raggi; John R Votaw
Journal:  J Nucl Cardiol       Date:  2009-11-24       Impact factor: 5.952

5.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve.

Authors:  Bernhard A Herzog; Lars Husmann; Ines Valenta; Oliver Gaemperli; Patrick T Siegrist; Fabian M Tay; Nina Burkhard; Christophe A Wyss; Philipp A Kaufmann
Journal:  J Am Coll Cardiol       Date:  2009-07-07       Impact factor: 24.094

6.  Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms.

Authors:  K F Van Train; E V Garcia; J Maddahi; J Areeda; C D Cooke; H Kiat; G Silagan; R Folks; J Friedman; L Matzer
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

7.  Optimization of Rb-82 PET acquisition and reconstruction protocols for myocardial perfusion defect detection.

Authors:  Jing Tang; Arman Rahmim; Riikka Lautamäki; Martin A Lodge; Frank M Bengel; Benjamin M W Tsui
Journal:  Phys Med Biol       Date:  2009-05-06       Impact factor: 3.609

8.  Quantification of myocardial blood flow with 82Rb dynamic PET imaging.

Authors:  Mireille Lortie; Rob S B Beanlands; Keiichiro Yoshinaga; Ran Klein; Jean N Dasilva; Robert A DeKemp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-07-07       Impact factor: 9.236

9.  Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT.

Authors:  Timothy M Bateman; Gary V Heller; A Iain McGhie; John D Friedman; James A Case; Jan R Bryngelson; Ginger K Hertenstein; Kelly L Moutray; Kimberly Reid; S James Cullom
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

10.  Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease.

Authors:  Uchechukwu K Sampson; Sharmila Dorbala; Atul Limaye; Raymond Kwong; Marcelo F Di Carli
Journal:  J Am Coll Cardiol       Date:  2007-02-26       Impact factor: 24.094

View more
  13 in total

1.  Characterizing the normal range of myocardial blood flow with ⁸²rubidium and ¹³N-ammonia PET imaging.

Authors:  Jennifer M Renaud; Jean N DaSilva; Rob S B Beanlands; Robert A DeKemp
Journal:  J Nucl Cardiol       Date:  2013-05-09       Impact factor: 5.952

2.  PET should replace SPECT in cardiac imaging for diagnosis and risk assessment of patients with known or suspected CAD: Pro.

Authors:  Jamshid Maddahi; René R Sevag Packard
Journal:  J Nucl Cardiol       Date:  2017-04-10       Impact factor: 5.952

3.  Status of cardiovascular PET radiation exposure and strategies for reduction: An Information Statement from the Cardiovascular PET Task Force.

Authors:  James A Case; Robert A deKemp; Piotr J Slomka; Mark F Smith; Gary V Heller; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2017-05-16       Impact factor: 5.952

4.  Low-dose 3D (82)Rb PET.

Authors:  Piotr J Slomka; Daniel S Berman; Guido Germano
Journal:  J Nucl Cardiol       Date:  2012-12       Impact factor: 5.952

Review 5.  Noninvasive imaging in coronary artery disease.

Authors:  Ran Heo; Ryo Nakazato; Dan Kalra; James K Min
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

Review 6.  PET-Based Imaging of Ischemic Heart Disease.

Authors:  Kevin Chen; Edward J Miller; Mehran M Sadeghi
Journal:  PET Clin       Date:  2019-02-01

7.  Clinical performance of Rb-82 myocardial perfusion PET and Tc-99m-based SPECT in patients with extreme obesity.

Authors:  David T Harnett; Samir Hazra; Ronnen Maze; Brian A Mc Ardle; Ali Alenazy; Trevor Simard; Ellen Henry; Girish Dwivedi; Christopher Glover; Robert A deKemp; Ross A Davies; Terrence D Ruddy; Benjamin J W Chow; Rob S Beanlands; Benjamin Hibbert
Journal:  J Nucl Cardiol       Date:  2017-03-29       Impact factor: 5.952

8.  Implementation of a cardiac PET stress program: comparison of outcomes to the preceding SPECT era.

Authors:  Stacey Knight; David B Min; Viet T Le; Kent G Meredith; Ritesh Dhar; Santanu Biswas; Kurt R Jensen; Steven M Mason; Jon-David Ethington; Donald L Lappe; Joseph B Muhlestein; Jeffrey L Anderson; Kirk U Knowlton
Journal:  JCI Insight       Date:  2018-05-03

Review 9.  CFR and FFR assessment with PET and CTA: strengths and limitations.

Authors:  Ryo Nakazato; Ran Heo; Jonathon Leipsic; James K Min
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

10.  Myocardial perfusion imaging with PET.

Authors:  Ryo Nakazato; Daniel S Berman; Erick Alexanderson; Piotr Slomka
Journal:  Imaging Med       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.